Evaluation of the neuroprotective effect of dextromethorphan in the acute phase of ischaemic stroke

Archives of Medical Science

Volumn 7, Issue 3, 2011, Pages 465-469

  Mousavi, Seyed Ali ^a   Saadatnia, Mohammad ^b   Khorvash, Faribourz ^b   Hoseini, Tahereh ^a   Sariaslani, Payam ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Isfahan Research of NeuroSciences   (Iran)

Author keywords

Dextromethorphan; Neuroprotection; Stroke; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; DEXTROMETHORPHAN; PLACEBO;

ABSENCE OF SIDE EFFECTS; AGED; ARTICLE; BARTHEL INDEX; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; LOADING DRUG DOSE; MALE; METABOLITE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROPROTECTION; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; STUDENT T TEST;

EID: 79960442509     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2011.23413     Document Type: Article

References (20)

1. Biller J, Love BB. Vascullar disease of nervouse system. In: Bradlly WG. Neurology in clinical practice. Philadelphia 2004; 1197, 1239.
2. Davis S, Lees K, Donnan G. Treating the acute stroke patient as an emergency: current practices and future opportunities. Int J Clin Prac 2006; 60: 399-407.
3. Nakajima M, Doi H, Hirano T, Uchino M. Coronary flow velocity reserve in patients with ischemic stroke. Med Sci Monit 2009; 15: CR383-8.
4. Bern JL, Peck R. Dextromethorphan. An overview of safety issues. Drug Saf 1992; 7: 1909.
5. Britton P, Lu XC, Laskosky MS, Tortella FC. Dextromethorphan protects against cerebral injury following transient, but not permantent focal ischemia in rats. Life Sci 1997; 60: 1729-40. (Pubitemid 27225902)
6. Tortellan FC, et al. Dextromethrophan and neuromodulation: old drug coughs up new activities. Trends Phannacol Sci 1989; 10: 5017.
7. Swan JH, Evans MC, Meldrum BS. Long term development of selective neuronal loss and the mechanism of protection by 2amino7phosphonoheptanoatein rat model of incomplete forebrain ischemia. J Cereb Blood Flow Metab 1988; 8: 64-78. (Pubitemid 18045945)
8. Schmid Elsaesser R, Zausinger S, Hungerhuber E, Baethmann A, Reulen HJ. Monotherapy with dextromethorphan or tirilazed but not a combination of both improves out come after transient focal cerebral ischemia in rats. Exp Brain Res 1998; 122: 12-7.
9. Steinberg GK, Saleh J, Kunis D. Delayed treatment with dextromethorphan and dextrophan reduces cerebral damage after transient focal ischemia. Neurosci Lett 1988; 89: 193-7.
10. Steinberg GK, Yoon EJ, Kunis DM, Sun GH, Maier CM, Gran GA. Neuroprotection by N-methyl D aspartate antagonist in focal cerebral ischemia dependent on continued maintenance dosing. Neuroscience 1995; 64: 99-107.
11. Steinberg GK, George CP, DelaPaz R, Shibate DK, Gross T. Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits. Stroke 1988; 19: 111-28.
12. Kristensen HT. Simultaneous determination of dextromethorphan and its metabolites in human plasma by capillary electrophoresis. J Pharm Biomed Anal 1998; 18: 827-38. (Pubitemid 29057812)
13. Werling LL, Lauterbach EC, Calef U. Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action. Neurologist 2007; 13: 272-93. (Pubitemid 47396313)
14. Albers GW, Saens RE, Moses JA Jr, Choi DW. Safety and tolerance of oral dextromethorphan in patients at risk for brain ischemia. Stroke 1991; 22: 1075-7.
15. Albers GW, Saens RE, Moses JA Jr. Tolerability of oral dextromethorphan in patients with a history of brain ischemia. Clin Neuropharmacol 1992; 15: 509-14.
16. Albers GW, Atkinson RP, Kelley RE, Rosenbaum DM. Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Stroke 1995; 26: 254-8.
17. Safety, tolerability and pharmacokinetics of the N-methyl-D-aspartate antagonist Ro-01-6794/706 in patients with acute ischemic stroke. The Dextrorphan Study Group and Hoffmann-La Roche. Ann N Y Acad Sci 1995; 765: 249-61.
18. Steinberg GK, Saleh J, Kunis D, Delapaz R, Zarnegar SR. Protective effect of N-methyl D aspartate antagonists after focal cerebral ischemia in rahbits. Stroke 1989; 20: 1247-52. (Pubitemid 19226922)
19. Cheng YD, Al-KJwury L, Zivin JA. Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx 2004; 1: 36-45. (Pubitemid 46589340)
20. Albers GW, Goldberg MP, Choi DW. N-methyl D aspartate antagonists: ready for clinical trial in brain ischemia? Ann Neurol 1989; 25: 398-403.